Drug information systems formularies

McEvoy, G.K., Ed., Drug Information 2004, American Hospital Formulary System, American Society of Hospital Pharmacists, Bethesda, MD, 2004, pp. 2896-2923. 

The Drug Information Centre should always be available by telephone, but can also answer inquiries by mail, e-mail, Internet based formularies or by functions integrated into local technical systems, such as computerised medical records. 

McEvoy GK (ed.). American hospital formulary service drug information 2001. Bethesda, MD American Society of Health-System Pharmacists, 2001. 

American Hospital Formulary Services (AHFS) Drug Information, American Society of Health-System Pharmacists, Inc., Betheda MD (1996) p. 1931. 

The AHFS Framework enables developers to easily embed drug content into pharmacy and clinical information systems. It can be used to rapidly integrate two respected drug knowledge bases the American Hospital Formulary Service (AHFS) Drug Information monographs, and First DataBank s NDDF Plus. Combined, they allow healthcare professionals to have seamless access to comprehensive drug information, within their usual work-flow systems. 

A health system can own and operate its own drug information service (DIS) to serve the drug information needs of pharmacists, physicians, nurses, and other professional staffs within the system. In addition to drug information, the DIS focuses on drug formulary and pharmacoeconomic issues of drug products and drug use within the system. 

May P, Stein EJ, Ryter RJ, Hirsh FS, Michel B, Levy RP (1976) Cushing syndrome from percutaneous absorption of triamcinolone cream. Arch Intern Med 136 612-613 McDaniel DH, Blatchley DM, Welton WA (1982) Adverse systemic reaction to dinitrochlorobenzene. Arch Dermatol 118 371 McEvoy G (1989) American hospital formulary service drug information 89. American Society of Hospital Pharmacists, Bethesda... 

A stand-alone outpatient drug benefit manager might only worry about the drug cost for the nonhospitalized portion of the therapy. The overall health system may be at financial risk for all elements of outpatient and inpatient care. Because each element of the system may be responsible for a different component of the total cost of care, the cost-impact of a given drug product selection may be different for each element. The societal perspective" often represents yet another view of drug costs in that it incorporates nonhealthcare costs and the value of lost days of work and disability. Formulary inclusion is not routinely based on that level of evaluation, but public policy may be influenced by that information. 

---